BB BIOTECH AG

BION
Delayed Quote. Delayed  - 01/21 11:30:06 am
67.2CHF -3.17%

BB Biotech : Interim report as at March 31, 2021

04/25/2021 | 09:12am

BB Biotech invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. It focuses on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit-growth potential.

Disclaimer

BB Biotech AG published this content on 23 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 April 2021 13:11:09 UTC.

© Publicnow 2022
Copier lien
All news about BB BIOTECH AG
11h ago
11h ago
11h ago
11h ago
12/09